Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat

[1]  C. Finch,et al.  Cloning of hippocampal poly(A) RNA sequences that increase after entorhinal cortex lesion in adult rat. , 1991, Brain research. Molecular brain research.

[2]  C. Cotman,et al.  Increased expression of the embryonic form of a developmentally regulated mRNA in Alzheimer's disease , 1990, Neuroscience Letters.

[3]  C. Cotman,et al.  Selective alterations of RNA in rat hippocampus after entorhinal cortex lesioning. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Steven A. Johnson,et al.  Altered Gene Expression in Alzheimer's Disease Brain Tissue , 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[5]  P. Mcgeer,et al.  Immune System Response in Alzheimer's Disease , 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[6]  W. Tourtellotte,et al.  Changes in brain gene expression shared by scrapie and Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Tschopp,et al.  Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: identity to sulfated glycoprotein 2, a constituent of rat testis fluid. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[8]  C. Olsson,et al.  Induction of the TRPM-2 gene in cells undergoing programmed death , 1989, Molecular and cellular biology.

[9]  Kenneth S. Kosik,et al.  Developmentally regulated expression of specific tau sequences , 1989, Neuron.

[10]  P. Hudson,et al.  Molecular cloning and characterization of the novel, human complement‐associated protein, SP‐40,40: a link between the complement and reproductive systems. , 1989, The EMBO journal.

[11]  P. Eikelenboom,et al.  Complement activation in amyloid plaques in Alzheimer’s dementia , 1988, Virchows Archiv. B, Cell pathology including molecular pathology.

[12]  P. Gilna,et al.  Identification of an androgen-repressed mRNA in rat ventral prostate as coding for sulphated glycoprotein 2 by cDNA cloning and sequence analysis. , 1989, The Biochemical journal.

[13]  S. Styren,et al.  Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease , 1988, Neurobiology of Aging.

[14]  Steven A. Johnson,et al.  Selective reduction of mRNA for the β-amyloid precursor protein that lacks a Kunitz-type protease inhibitor motif in cortex from Alzheimer brains , 1988, Experimental Neurology.

[15]  P. Davies,et al.  Reexpression of a developmentally regulated antigen in Down syndrome and Alzheimer disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Cleveland,et al.  Neurofilament and tubulin expression recapitulates the developmental program during axonal regeneration: induction of a specific beta-tubulin isotype. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[17]  C. Cotman,et al.  Synaptic plasticity and functional stabilization in the hippocampal formation: possible role in Alzheimer's disease. , 1988, Advances in neurology.

[18]  M. Griswold,et al.  Biosynthesis and molecular cloning of sulfated glycoprotein 2 secreted by rat Sertoli cells. , 1987, Biochemistry.

[19]  G. V. Van Hoesen,et al.  Perforant pathway changes and the memory impairment of Alzheimer's disease , 1986, Annals of neurology.

[20]  C. Cotman,et al.  Plasticity of hippocampal circuitry in Alzheimer's disease. , 1985, Science.

[21]  David M. A. Mann,et al.  The neuropathology of Alzheimer's disease: A review with pathogenetic, aetiological and therapeutic considerations , 1985, Mechanisms of Ageing and Development.

[22]  C. Cotman,et al.  Cell biology of synaptic plasticity. , 1984, Science.

[23]  G. V. Van Hoesen,et al.  Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. , 1984, Science.

[24]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[25]  B. Hoffman,et al.  A simple and very efficient method for generating cDNA libraries. , 1983, Gene.

[26]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[27]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[28]  C. Cotman,et al.  Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells , 1978, Nature.